This trend reflects a growing recognition of obesity as a serious medical condition requiring comprehensive biotechnological interventions​​.
The obesity drug market is expanding rapidly, driven by an increased understanding of the disease’s complexity and the demand for more effective treatments. This trend reflects a growing recognition of obesity as a serious medical condition requiring comprehensive biotechnological interventions​​.